AllianceBernstein
ICPT

AllianceBernstein’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

AllianceBernstein’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-40,000
Closed -$2.46M – 3153
2018
Q1 		$2.46M Buy
+40,000
New +$2.41M ﹤0.01% 1692

AllianceBernstein's ICPT Position: Q4 2023 in Review

AllianceBernstein sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 1,542,896 shares — an estimated $28.6M sold.

AllianceBernstein first reported a position in ICPT in Q2 2013 and held it in 42 quarters. The position peaked at $51.5M in Q1 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • AllianceBernstein reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • AllianceBernstein sold 1,542,896 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $28.6M.
  • AllianceBernstein first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 42 quarters.
  • AllianceBernstein's Intercept Pharmaceuticals, Inc. position peaked at $51.5M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on AllianceBernstein's 13F filing for Q4 2023, filed 14 Feb 2024.